Percutaneous mitral valve repair: the beginning of the end or the end of the beginning?

Alec Vahanian, Dominique Himbert, Eric Brochet, David Messika-Zeitoun, Alec Vahanian, Dominique Himbert, Eric Brochet, David Messika-Zeitoun

Abstract

The new percutaneous mitral valve repair techniques are at an early stage. Preliminary series show that they are feasible; however, they need to be further evaluated in comparison with contemporary treatment to accurately assess their efficiency. Potential applications may benefit high-risk patients after thorough evaluation.

References

    1. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382–94. doi: 10.1016/S0140-6736(09)60692-9.
    1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11. doi: 10.1016/S0140-6736(06)69208-8.

    2. f1000 Factor 3.0 Recommended

      Evaluated by Wilbert Aronow 23 Oct 2006

    1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231–43. doi: 10.1016/S0195-668X(03)00201-X.
    1. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A, Task Force on the Management of Valvular Hearth Disease of the European Society of Cardiology. ESC Committee for Practice Guidelines Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230–68.

    2. Changes Clinical Practice

      f1000 Factor 9.0 Exceptional

      Evaluated by Raimund Erbel 10 May 2007

    1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:e1–e148. doi: 10.1016/j.jacc.2006.05.021.
    1. Gillinov AM, Blackstone EH, Nowicki ER, Slisatkorn W, Al-Dossari G, Johnston DR, George KM, Houghtaling PL, Griffin B, Sabik JF, III, Svensson LG. Valve repair versus valve replacement for degenerative mitral valve disease. J Thorac Cardiovasc Surg. 2008;135:885–93. doi: 10.1016/j.jtcvs.2007.11.039.
    1. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde JL, Butchart EG, Ravaud P, Vahanian A. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358–65. doi: 10.1093/eurheartj/ehm001.

    2. f1000 Factor 3.0 Recommended

      Evaluated by Elliot Rapaport 06 Sep 2007

    1. Gillinov AM, Blackstone EH, Rajeswaran J, Mawad M, McCarthy PM, Sabik JF, III, Shiota T, Lytle BW, Cosgrove DM. Ischemic versus degenerative mitral regurgitation: does etiology affect survival? Ann Thorac Surg. 2005;80:811–9. doi: 10.1016/j.athoracsur.2005.03.134.
    1. Gammie JS, O'Brien SM, Griffith BP, Ferguson TB, Peterson ED. Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation. 2007;115:881–7. doi: 10.1161/CIRCULATIONAHA.106.634436.
    1. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, La Canna G. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122:674–81. doi: 10.1067/mtc.2001.117277.
    1. St Goar FG, Fann JI, Komtebedde J, Foster E, Oz MC, Fogarty TJ, Feldman T, Block PC. Endovascular edge-to-edge mitral valve repair: short-term results in a porcine model. Circulation. 2003;108:1990–3. doi: 10.1161/.
    1. Silvestry FE, Rodriguez LL, Herrmann HC, Rohatgi S, Weiss SJ, Stewart WJ, Homma S, Goyal N, Pulerwitz T, Zunamon A, Hamilton A, Merlino J, Martin R, Krabill K, Block PC, Whitlow P, Tuzcu EM, Kapadia S, Gray WA, Reisman M, Wasserman H, Schwartz A, Foster E, Feldman T, Wiegers SE. Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiogr. 2007;20:1131–40. doi: 10.1016/j.echo.2007.02.003.
    1. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, St Goar F, Rodriguez L, Silvestry F, Schwartz A, Sanborn TA, Condado JA, Foster E. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol. 2005;46:2134–40. doi: 10.1016/j.jacc.2005.07.065.
    1. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D, EVEREST Investigators Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009;54:686–94. doi: 10.1016/j.jacc.2009.03.077.
    1. Webb JG, Maisano F, Vahanian A, Munt B, Naqvi TZ, Bonan R, Zarbatany D, Buchbinder M. Percutaneous suture edge-to-edge repair of the mitral valve. Eurointervention. 2009;5:86–9.
    1. Foster E, Wasserman HS, Gray W, Homma S, Di Tullio MR, Rodriguez L, Stewart WJ, Whitlow P, Block P, Martin R, Merlino J, Herrmann HC, Wiegers SE, Silvestry FE, Hamilton A, Zunamon A, Kraybill K, Gerber IL, Weeks SG, Zhang Y, Feldman T. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol. 2007;100:1577–83. doi: 10.1016/j.amjcard.2007.06.066.
    1. Herrmann HC, Kar S, Siegel R, Fail P, Loghin C, Lim S, Hahn R, Rogers JH, Bommer WJ, Wang A, Berke A, Lerakis S, Kramer P, Wong SC, Foster E, Glower D, Feldman T, EVEREST Investigators Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention. 2009;4:437–42.
    1. Byrne MJ, Kaye DM, Mathis M, Reuter DG, Alferness CA, Power JM. Percutaneous mitral annular reduction provides continued benefit in an ovine model of dilated cardiomyopathy. Circulation. 2004;110:3088–92. doi: 10.1161/01.CIR.0000146904.13677.E4.
    1. Schoffer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC, Levy WC, Mauri L, Feldman T, Kwong RY, Kaye DM, Duffy SJ, Tübler T, Degen H, Brandt MC, Van Bibber R, Goldberg S, Reuter DG, Hoppe UC. Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON mitral annuloplasty device European Union study. Circulation. 2009;120:326–33. doi: 10.1161/CIRCULATIONAHA.109.849885.
    1. Sack S, Kahlert P, Bilodeau L, Pièrard LA, Lancellotti P, Legrand V, Bartunek J, Vanderheyden M, Hoffmann R, Schauerte E, Shiota T, Marks DS, Erbel R, Ellis SG. Percutaneous transvenous mitral annuloplasty: initial human experience with a novel coronary sinus implant device. Circ Cardiovasc Intervent. 2009;2:277–84. doi: 10.1161/CIRCINTERVENTIONS.109.855205.
    1. Webb JG, Harnek J, Munt BI, Kimblad PO, Chandavimol M, Thompson CR, Mayo JR, Solem JO. Percutaneous transvenous mitral annuloplasty: initial human experience with device implantation in the coronary sinus. Circulation. 2006;113:851–5. doi: 10.1161/CIRCULATIONAHA.105.591602.
    1. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381–7. doi: 10.1016/j.jacc.2004.09.073.
    1. Bax JJ, Braun J, Somer ST, Klautz R, Holman ER, Versteegh MI, Boersma E, Schalij MJ, van der Wall EE, Dion RA. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation. 2004;110(11) Suppl 1:II103–8. doi: 10.1161/01.CIR.0000138196.06772.4e.
    1. Maselli D, Guarracino F, Chiaramonti F, Mangia F, Borelli G, Minzioni G. Percutaneous mitral annuloplasty: an anatomic study of human coronary sinus and its relation with mitral valve annulus and coronary arteries. Circulation. 2006;114:377–80. doi: 10.1161/CIRCULATIONAHA.105.609883.
    1. Choure AJ, Garcia MJ, Hesse B, Sevensma M, Maly G Greenberg NL, Borzi L, Ellis S, Tuzcu M, Kapadia SR. In vivo analysis of the anatomical relationship of coronary sinus to mitral annulus and left circumflex coronary artery using cardiac multidetector computed tomography implications for percutaneous coronary sinus mitral annuloplasty. J Am Coll Cardiol. 2006;48:1938–45. doi: 10.1016/j.jacc.2006.07.043.
    1. Tops LF, Van de Veire NR, Schuijf JD, de Roos A, van der Wall EE, Schalij MJ, Bax JJ. Noninvasive evaluation of coronary sinus anatomy and its relation to the mitral annulus: implications for percutaneous mitral annuloplasty. Circulation. 2007;115:1426–32. doi: 10.1161/CIRCULATIONAHA.106.677880.
    1. Rosengart TK, Feldman T, Borger MA, Vassiliades TA, Jr., Gillinov AM, Hoercher KJ, Vahanian A, Bonow RO, O'Neill W, American Heart Association Council on Cardiovascular Surgery and Anesthesia. American Heart Association Council on Clinical Cardiology. Functional Genomics and Translational Biology Interdisciplinary Working Group. Quality of Care and Outcomes Research Interdisciplinary Working Group Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia Council on Clinical Cardiology Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2008;117:1750–67. doi: 10.1161/CIRCULATIONAHA.107.188525.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir